174 related articles for article (PubMed ID: 27466080)
1. Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes.
Boriani G; Laroche C; Diemberger I; Popescu MI; Rasmussen LH; Petrescu L; Crijns HJGM; Tavazzi L; Maggioni AP; Lip GYH
Sci Rep; 2016 Jul; 6():30271. PubMed ID: 27466080
[TBL] [Abstract][Full Text] [Related]
2. Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation.
Guo Y; Wang H; Zhao X; Zhang Y; Zhang D; Ma J; Wang Y; Lip GY
Int J Cardiol; 2013 Oct; 168(5):4678-84. PubMed ID: 23972369
[TBL] [Abstract][Full Text] [Related]
3. Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study.
Violi F; Pastori D; Perticone F; Hiatt WR; Sciacqua A; Basili S; Proietti M; Corazza GR; Lip GY; Pignatelli P;
BMJ Open; 2015 May; 5(5):e008026. PubMed ID: 25998039
[TBL] [Abstract][Full Text] [Related]
4. Comparison of associations of outcomes after stroke with estimated GFR using Chinese modifications of the MDRD study and CKD-EPI creatinine equations: results from the China National Stroke Registry.
Wang X; Luo Y; Wang Y; Wang C; Zhao X; Wang D; Liu L; Liu G; Wang Y;
Am J Kidney Dis; 2014 Jan; 63(1):59-67. PubMed ID: 24100127
[TBL] [Abstract][Full Text] [Related]
5. Renal dysfunction and atrial fibrillation recurrence following cardioversion.
Schmidt M; Daccarett M; Rittger H; Marschang H; Holzmann S; Jung P; Bojanic D; Ketteler M; Brachmann J; Rieber J
J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1092-8. PubMed ID: 21489032
[TBL] [Abstract][Full Text] [Related]
6. Association between impaired renal function and stroke outcome in patients with versus without atrial fibrillation.
Pan Y; Jing J; Chen W; Wang Y; He Y
Eur J Neurol; 2018 Aug; 25(8):1041-1048. PubMed ID: 29512928
[TBL] [Abstract][Full Text] [Related]
7. Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).
Roldán V; Marín F; Fernández H; Manzano-Fernández S; Gallego P; Valdés M; Vicente V; Lip GY
Am J Cardiol; 2013 Apr; 111(8):1159-64. PubMed ID: 23337836
[TBL] [Abstract][Full Text] [Related]
8. Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase.
Proietti M; Laroche C; Nyvad O; Haberka M; Vassilikos VP; Maggioni AP; Boriani G; Lip GYH;
Int J Cardiol; 2017 Dec; 248():166-172. PubMed ID: 28859841
[TBL] [Abstract][Full Text] [Related]
9. Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry.
Esteve-Pastor MA; Rivera-Caravaca JM; Roldán-Rabadán I; Roldán V; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
Thromb Haemost; 2018 Feb; 118(2):279-287. PubMed ID: 29443369
[TBL] [Abstract][Full Text] [Related]
10. Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation Registries.
Rohla M; Pecen L; Cemin R; Patti G; Siller-Matula JM; Schnabel RB; Huber K; Kirchhof P; De Caterina R
Circ Cardiovasc Qual Outcomes; 2021 Jun; 14(6):e006852. PubMed ID: 34078099
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis.
Hijazi Z; Hohnloser SH; Oldgren J; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Reilly PA; Siegbahn A; Yusuf S; Wallentin L
Circulation; 2014 Mar; 129(9):961-70. PubMed ID: 24323795
[TBL] [Abstract][Full Text] [Related]
12. Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Fauchier L; Vourc'h P; Andres CR; Taillandier S; Halimi JM; Lip GY
J Am Coll Cardiol; 2013 May; 61(20):2079-87. PubMed ID: 23524209
[TBL] [Abstract][Full Text] [Related]
13. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
14. Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation.
Dan GA; Badila E; Weiss E; Laroche C; Boriani G; Dan A; Tavazzi L; Maggioni AP; Crijns HJ; Popescu R; Blommaert D; Streb W; Lip GYH;
Int J Cardiol; 2018 Mar; 254():136-141. PubMed ID: 29407080
[TBL] [Abstract][Full Text] [Related]
15. The CHA
Beyer-Westendorf J; Kreutz R; Posch F; Ay C
Int J Cardiol; 2018 Feb; 253():71-77. PubMed ID: 29306476
[TBL] [Abstract][Full Text] [Related]
16. Impaired renal function in stroke patients with atrial fibrillation.
Sauer EM; Sauer R; Kallmünzer B; Blinzler C; Breuer L; Huttner HB; Schwab S; Köhrmann M
J Stroke Cerebrovasc Dis; 2014; 23(5):1225-8. PubMed ID: 24280266
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Fauchier L; Vourc'h P; Andres CR; Taillandier S; Halimi JM; Lip GYH
Chest; 2014 Jun; 145(6):1370-1382. PubMed ID: 24356875
[TBL] [Abstract][Full Text] [Related]
18. Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).
Poli D; Antonucci E; Zanazzi M; Grifoni E; Testa S; Ageno W; Palareti G
Thromb Haemost; 2012 Jun; 107(6):1100-6. PubMed ID: 22535516
[TBL] [Abstract][Full Text] [Related]
19. Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry.
Boriani G; Proietti M; Laroche C; Diemberger I; Popescu MI; Riahi S; Shantsila A; Dan GA; Tavazzi L; Maggioni AP; Lip GYH;
Int J Cardiol; 2018 Nov; 271():68-74. PubMed ID: 30001945
[TBL] [Abstract][Full Text] [Related]
20. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
